Back
Astellas Pharma Quote, Financials, Valuation and Earnings
Sell
40
ALPMF
Astellas Pharma
Last Price:
9.56
Seasonality Move:
5.36%
7 Day Trial
ALL ACCESS PASS
$
7
Astellas Pharma Price Quote
$9.56
Astellas Pharma Key Stats
Sell
40
Astellas Pharma (ALPMF)
is a Sell
Day range:
$9.56 - $9.56
52-week range:
$9.13 - $17.00
Dividend yield:
4.87%
P/E ratio:
23.87
P/S ratio:
1.57
P/B ratio:
1.61%
Volume:
250
Avg. volume:
2.2K
1-year change:
-41.71%
Market cap:
$17.1B
Revenue:
$11.2B
EPS:
$-0.01
How Much Does Astellas Pharma Make?
-
How Much Are Astellas Pharma's Sales Annually?
ALPMF Revenues are $11.2B -
How Much Profit Does Astellas Pharma's Make A Year?
ALPMF net income is $731M
Is Astellas Pharma Growing As A Company?
-
What Is Astellas Pharma's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0% -
What Is Astellas Pharma's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is -0.71%
Astellas Pharma Stock Price Performance
-
Did Astellas Pharma Stock Go Up Last Month?
Astellas Pharma share price went down by -0.35% last month -
Did ALPMF's Share Price Rise Over The Last Year?
ALPMF share price fell by -41.71% over the past 1 year
What Is Astellas Pharma 52-Week High & Low?
-
What Is Astellas Pharma’s 52-Week High Share Price?
Astellas Pharma has traded as high as $17.00 over the past 52 weeks -
What Is Astellas Pharma’s 52-Week Low Share Price?
Astellas Pharma has traded as low as $9.13 over the past 52 weeks
Astellas Pharma Price To Free Cash Flow
-
Is Astellas Pharma Stock Overvalued?
Astellas Pharma is trading at a price to free cash flow ratio of 18.15 -
Is Astellas Pharma Stock Undervalued?
Astellas Pharma EV to Free Cash Flow ratio is 22.37 -
What Is Astellas Pharma’s Price Earnings Growth Ratio?
ALPMF PEG ratio is 0.00 -
Is Astellas Pharma Trading At A Premium To Earnings?
Astellas Pharma EV to EBIT ratio is 104.64
Is It Risky To Buy Astellas Pharma?
-
How Much Debt Does Astellas Pharma Have?
Total long term debt quarterly is $6.2B -
How Much Cash Does Astellas Pharma Have?
Cash and short term investments quarterly total is $2B -
What Is Astellas Pharma’s Book Value Per Share?
Book value per share is 5.95
Is Astellas Pharma Cash Flow Positive?
-
What Is ALPMF Cash Flow From Operations?
Cash flow from operations (TTM) is $1.6B -
What Is Astellas Pharma’s Cash Flow From Financing?
Cash flow from financing (TTM) is $3.1B -
What Is Astellas Pharma’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$5.8B
Astellas Pharma Return On Invested Capital
-
Is Management Doing A Good Job?
ALPMF return on invested capital is -0.14% -
What Is Astellas Pharma Return On Assets?
ROA measures how assets are converting to revenues and is -0.09% -
What Is ALPMF Return On Equity?
ROE is a measure of profitability and is -0.18%
Astellas Pharma Earnings Date & Stock Price
-
What Is Astellas Pharma's Stock Price Today?
A single share of ALPMF can be purchased today for 9.56 -
What Is Astellas Pharma’s Stock Symbol?
Astellas Pharma trades on the otcm under the ticker symbol: ALPMF -
When Is Astellas Pharma’s Next Earnings Date?
The next quarterly earnings date for Astellas Pharma is scheduled on May 19, 2024 -
When Is ALPMF's next ex-dividend date?
Astellas Pharma's next ex-dividend date is March 31, 2025 -
How To Buy Astellas Pharma Stock?
You can buy Astellas Pharma shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Astellas Pharma Competitors
-
Who Are Astellas Pharma's Competitors?
Below is a list of companies who compete with Astellas Pharma or are related in some way:
Astellas Pharma Dividend Yield
-
What Is ALPMF Dividend Yield?
Astellas Pharma’s dividend yield currently is 4.87% -
What Is Astellas Pharma’s Payout Ratio?
Astellas Pharma’s payout ratio is -4195.08% -
When Did Astellas Pharma Last Pay A Dividend?
The latest dividend pay date is May 19, 2024 -
What Is Astellas Pharma’s Dividend Per Share?
Astellas Pharma pays a dividend of $0.00 per share
Astellas Pharma Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | -71.01% | 0% |
| Revenue: | 0.17% | 0% |
Analyst Recommendations
| Buy Recommendations: | 0 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 0.00 |
| Downside from Last Price: | -100% |